Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio
$449Million
Equity Portfolio Value
Last Reported on: 15 Apr, 2024
About Medicxi Ventures Management (Jersey) Ltd and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $296.2 Millions as of 31 Dec, 2023.
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, MRUS, PHAT. The fund has invested 53.6% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 14.8% of portfolio in MERUS N V.
The fund managers got completely rid off VAXCYTE INC (PCVX) stocks.
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, MRUS, PHAT. The fund has invested 53.6% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 14.8% of portfolio in MERUS N V.
The fund managers got completely rid off VAXCYTE INC (PCVX) stocks.
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| PHATHOM PHARMACEUTICALS INC | 98.48 |
Additions to existing portfolio by Medicxi Ventures Management (Jersey) Ltd
Reductions
| Ticker | % Reduced |
|---|---|
| MERUS N V | -26.94 |
Medicxi Ventures Management (Jersey) Ltd reduced stake in above stock
Sold off
Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd
Last Reported on: 15 Apr, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AURA | AURA BIOSCIENCES INC | 5.31 | 3,039,890 | 23,863,200 | UNCHANGED | 0.00 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 50.22 | 19,963,200 | 225,584,000 | UNCHANGED | 0.00 | |
| MRUS | MERUS N V | 11.72 | 1,169,030 | 52,641,300 | REDUCED | -26.94 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 15.11 | 2,869,560 | 67,865,200 | UNCHANGED | 0.00 | |
| PHAT | PHATHOM PHARMACEUTICALS INC | 17.65 | 7,464,570 | 79,273,800 | ADDED | 98.48 |